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Background: Irrational prescribing of over-the-counter (OTC) medicines in general practice is common in Southern
Europe. Recent findings from a research project funded by the European Commission (FP7), the “OTC SOCIOMED”,
conducted in seven European countries, indicate that physicians in countries in the Mediterranean Europe region
prescribe medicines to a higher degree in comparison to physicians in other participating European countries. In
light of these findings, a feasibility study has been designed to explore the acceptance of a pilot educational
intervention targeting physicians in general practice in various settings in the Mediterranean Europe region.
Methods: This feasibility study utilized an educational intervention was designed using the Theory of Planned
Behaviour (TPB). It took place in geographically-defined primary care areas in Cyprus, France, Greece, Malta, and
Turkey. General Practitioners (GPs) were recruited in each country and randomly assigned into two study groups in
each of the participating countries. The intervention included a one-day intensive training programme, a poster
presentation, and regular visits of trained professionals to the workplaces of participants. Reminder messages and
email messages were, also, sent to participants over a 4-week period. A pre- and post-test evaluation study design
with quantitative and qualitative data was employed. The primary outcome of this feasibility pilot intervention was
to reduce GPs’ intention to provide medicines following the educational intervention, and its secondary outcomes
included a reduction of prescribed medicines following the intervention, as well as an assessment of its practicality
and acceptance by the participating GPs.
Results: Median intention scores in the intervention groups were reduced, following the educational intervention,
in comparison to the control group. Descriptive analysis of related questions indicated a high overall acceptance
and perceived practicality of the intervention programme by GPs, with median scores above 5 on a 7-point
Likert scale.
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Conclusions: Evidence from this intervention will estimate the parameters required to design a larger study aimed
at assessing the effectiveness of such educational interventions. In addition, it could also help inform health policy
makers and decision makers regarding the management of behavioural changes in the prescribing patterns of
physicians in Mediterranean Europe, particularly in Southern European countries.
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Patient safety has been noted as an important area of
public health care and an increasingly growing area of
health services and policy research over the past few
years [1]. The focus of such research tends to be mainly
on hospital care, [2] whereas major sources of harm
within primary care settings have yet to be fully ex-
plored [3]. There is evidence that irrational prescribing
in primary care may introduce considerable harm,
resulting in a number of hospital admissions due to
adverse drug events [4]. Furthermore, a recent study
indicated high-risk prescribing was more common in
primary care patients who were being prescribed medi-
cines intended for long-term use [3]. Based on the
rational prescribing definition of the World Health Or-
ganisation (http://www.who.int/mediacentre/factsheets/
fs338/en/), rational use of medicines requires that
“patients receive medications appropriate to their clin-
ical needs, in doses that meet their own individual re-
quirements, for an adequate period of time, and at the
lowest cost to them and their community”.
However, trends in recent decades include the changing
status in the provision of medicines from Prescription-
Only Medicines (POMs) to Over-The-Counter (OTC)
medicines, frequently provided without prescription for
minor ailments in many countries. Although the use of
OTC medicines is steadily rising, [5] and concerns about
inappropriate treatment and adverse medicine reactions
have been raised, [6] this subject does not appear to have
received the attention it deserves in general practice re-
search, resulting in a serious evidence gap, particularly in
Europe [7,8].
Problems relating to irrational prescribing, provision and
use of both POMs and OTC medicines, and the subse-
quent impact on patient safety, appear to be more severe
in countries without a well-organized primary care system
or in countries where a gap exists between legislation and
practice. In Greece, for example, although many medicines
are not specifically defined by the existing legislation as
OTCs, they can still be obtained without prescription. An-
tibiotics are such an example, with Greece being ranked as
having one of the highest antimicrobial resistance rates
in Europe [9]. This problem is further exacerbated as
Greek primary care patients have a tendency to oftenexchange OTC medicines with friends and relatives
without seeking advice from either their General Practi-
tioner (GP) [7] or pharmacist.
There is a current discussion about the role of GPs
regarding their role in monitoring the use of the OTC
medicines by their patients, and there is evidence that
well-trained GPs can reduce the irrational use of OTC
medicines and, thus, improve patient safety [10]. Within
this context, a European project was developed, receiv-
ing funding by the European Commission through the
Seventh Framework Programme (FP7), and focusing on
“Assessing The Over-The-Counter Medications In Pri-
mary Care And Translating The Theory Of Planned Be-
haviour Into Interventions (OTC SOCIOMED)”(EU 7th
FP n°223654-06/05/08)”. Its primary objective was to as-
sess the extent of irrational prescribing jointly with the
provision of OTC medicines in Southern European coun-
tries and to identify factors which influence the intention
of GPs and pharmacists towards the provision of OTC
medicines and the intention of patients/clients towards
the consumption of OTC medicines. The design and im-
plementation of a pilot intervention has been included
among the objectives of this European collaborative pro-
ject. Within the framework of this project, it was deemed
important to explore the extent to which the empirical
and descriptive research implemented in this European
project could be translated into actions and policy. Educa-
tional interventions have been shown to improve the qual-
ity of prescribing, which in turn may lead to reduction in
polypharmacy and its associated high societal costs [11].
GPs and other frontline physicians serving in primary care
appear to be an appropriate group of health care profes-
sionals to target in such interventions [12]. Although early
conceptual models of health education and modern ver-
sions of health promotion indicate that interventions
should focus on changeable behaviours and objectives
[13], interventions testing behavioural models in this area
of medical research are scarce.
From the empirical and descriptive research that was
carried out in the first steps of this project, we identified
that positive attitude towards prescribed medicines and
social pressure (subjective norm category of the theory of
planed behaviour) was found to affect the GPs’ intention
to provide medicines. In addition, a gender difference was
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provide a greater number of medicines to their patients
compared to their male colleagues. Based on these obser-
vational findings we designed a pilot educational interven-
tion with the aim of establishing the extent to which the
GPs’ intention and behaviour in terms of medicine
provision, mostly on prescribing and advice on the use of
OTC medicines, may be affected by the intervention. We
purposively focused on GPs only and not on other individ-
uals (i.e. patients and pharmacists) regarding medicine
provision and use. The reason for this was because we
wanted to measure the effect of the intervention on GPs
without the measured effect being artificially enhanced by
the involvement of other partners, and we wished to draw
conclusions specifically on the acceptance of such an
intervention by this group. Our key research question and
interest was to explore whether the implemented educa-
tional intervention in primary care would be effective,
feasible and acceptable to be utilized prospectively as the
basis of a larger scale study.
Thus, the main aim of this paper is to report on the
design of this educational intervention, as well as the mea-
sured outcomes of its implementation. Among the objec-
tives of this study was the presentation of the key
components of the study with a focus on the psychological
constructs to predict clinical behaviour and explore the ac-
ceptance and practicality of this educational intervention.
Theoretical framework
The TPB was used as the theoretical framework for the
design of this feasibility study. The TPB seeks to explain
why people perform certain actions. According to the
TPB, a person’s intentions are a good predictor of their
behaviour. The stronger the intention to perform a par-
ticular behaviour, the more likely the person is to per-
form that behaviour. The model states that the intention
to carry out an action is influenced by the person’s be-
liefs (behavioural attitudes), the social pressure to con-
form to the expectations of others (subjective norms),
and their perceived ability to carry out the action (per-
ceived behavioural control) [14].
TPB states that attitudes towards behaviour are deter-
mined by the individual’s evaluation of the outcomes
associated with the behaviour. The more positively the
person evaluates the likely outcomes and believes that
the behaviour will achieve these outcomes, the more
likely it is that this person will perform the behaviour.
Subjective norms refer to the extent to which a person
believes that significant individuals or groups (e.g. parents,
spouse, close friend, co-workers, doctor or accountant)
will approve or disapprove of their performing the behav-
iour. The more the person believes that people with whom
he or she is motivated to comply think that he or she
should perform the behaviour, the more likely it is that theperson will feel social pressure to perform this behaviour
[15]. The TPB has been known to be a useful method to
identify factors relevant to prescribing patterns of GPs
within this same European research project [16].
Finally, perceived behavioural control refers to the ex-
tent to which the individual believes they can control
their behaviour and this includes beliefs about factors
that may hinder or promote the behaviour. The more a
person believes s/he has control over the action to be




A feasibility study was designed to assist the OTC
SOCIOMED FP7 project and in particular to assess the
acceptance and practicality of the implemented pilot
educational intervention study. The project received ap-
proval by local authorities and National Bioethics Com-
mittees in the participating countries (CY No: EEBK
EP2010 01.16; FR No: EGY/NDS/AR105323; GR No:
4483/31-5-2010; MT No: HEC23/10-07.10.2010; TR No:
2010-6/1).
Study setting
One to two geographically-defined Primary Health Care
(PHC) areas in each of the five Mediterranean countries,
(Cyprus, France, Greece, Malta and Turkey), were selected
for the pilot intervention, representing a mix of urban,
rural and semi-urban distinct setting characteristics within
the GP community. For clarification purposes and for rea-
sons serving the research questions, the participating
countries were divided into Eastern Mediterranean coun-
tries (Cyprus, Greece, Malta and Turkey) and Western
Mediterranean countries (France). The primary care sys-
tem that is currently operating in the countries of the East
Mediterranean basin, including the countries of Cyprus,
Greece, Turkey and Malta presents many similarities, par-
ticularly at the time that the study was carried out. Pri-
mary health care centres that deliver their services on a
24-hour basis, jointly with their peripheral posts, seem to
be the predominant model in rural areas in Malta, Greece,
and Cyprus; whilst this is a fact based on empirical
evidence, the number of GPs who work in solo practice
and serve the private sector appears to be increasing in
these countries. The specialty of general/family practice
has been recognized in all participating settings and only
certified GPs were invited to participate in our study.
Geographically-defined Primary Health Care areas were
established on the basis of the characteristics of the re-
gional organization for each primary health care system;
these definitions were extensively discussed and clarified
during the first meeting of the OTC SOCIOMED execu-
tive board to avoid variation of definition in terms of these
Lionis et al. BMC Family Practice 2014, 15:34 Page 4 of 15
http://www.biomedcentral.com/1471-2296/15/34characteristics across countries. All GP practices, public
(health centres and satellite practices) or private (solo and
group practices), in these areas were eligible for participa-
tion in the feasibility study (CY = 28, FR = 9200 (only solo
practices), GR = 66, MT= 72, TR = 21). A number of GP
practices in each study setting were then selected out of
the total eligible GP practices to be involved in the study,
based on the GPs’ acceptance to participate in the study,
with the exception of Malta, where all the eligible GP
practices were included in the study (CY = 10, FR = 527,
GR = 18, MT= 72, TR = 10). All the practising GPs serving
the selected GP practices in each study setting were in-
vited to participate in the study (CY = 76, FR = 527, GR =
34, MT= 90, TR = 41). The GPs who accepted this invita-
tion were the participants of this feasibility study (CY =
10, FR = 9, GR = 17, MT= 25, TR = 23). Informed consent
was obtained from all the study participants prior to par-
ticipation. Allocation of the GPs to the study groups was
made randomly in most settings, through assigning a
unique code to each GP, with the exception of Cyprus,
where allocation was based on the GPs’ availability to en-
gage in the intervention. Allocation of GPs to the study
groups in all the study settings was based on the GP prac-
tice they served in order to avoid the risk of contamin-
ation of individual GPs from information diffusion. For
these reasons, all participating GPs in any given practice
were allocated either to the intervention group or to the
control group.
Study description and implementation
The feasibility study was implemented in two phases, a
preparatory stage, where the observational findings from
this project were utilised for the design of the pilot educa-
tional intervention study (Phase 1), and a second phase in-
cluding both the implementation and evaluation of this
intervention (Phase 2).
Phase 1: Translating the findings of the OTC SOCIOMED
project into an intervention design
The key findings of a survey conducted in seven countries
in the framework of the OTC SOCIOMED project (work
packages 3 and 4, http://www.otcsociomed.uoc.gr), and
employing the TPB model to assess factors influencing the
beliefs and attitudes of GPs, pharmacists and patients/cli-
ents OTC medicines guided the design, content and
methods of this intervention study. For the purpose of this
European project we used the phrase “provision of med-
icines” for both prescribing and recommending of medi-
cines, based on local laws and regulations regarding
supply of medicines.
Translating evidence from international literature into
an intervention design A systematic review of inter-
national literature was also conducted within the OTCSOCIOMED project to better inform the design of this
feasibility study, given the fact that implementation of
interventions in the area of OTCs is still a neglected
subject in general practice/family medicine. Findings of
this review are presented in a separate paper, but we
have opted to mention those elements from our findings
deemed to be the most relevant for the purposes of the
OTC SOCIOMED project. The results of this review
suggest evidence is lacking for this particular topic, but
that common components of intervention studies within
the last 10 years include educational material and prac-
tice guidelines [17-22], computerised information and
timetables [23], conferences, seminars, workshops or
lectures [24-33] educational outreach visits [33-35], patient
and computerised feedback [36], reminders [37], graphical
displays [38], use of opinion of patients and advisors-
educators [39-41] and mailing questionnaires [42]. Evidence
from previous systematic reviews included in the scoping of
this project supports high effectiveness of structural [43]
and multifaceted interventions focusing on multiple targets,
compared to single and individual interventions [44].
Additionally, there were no studies focusing on com-
parative intervention effectiveness or studies “borrowing”
from the social sciences in terms of behavioural theories
and attempting to design an intervention in an interdiscip-
linary fashion. The review revealed limited evidence in
terms of the effectiveness of the interventions on pre-
scribed medicines in general practice and a serious
evidence gap on OTC rational provision and consump-
tion. In terms of the effectiveness of the interventions
assessed, educational types of intervention (e.g. courses,
aids, campaigns, face-to-face, academic detailing) ap-
peared to be the most promising in improving prescrib-
ing behaviour [24,45].
The aforementioned interventions were studied in
depth to help us structure our own intervention. Never-
theless, it is important to mention in some cases the ob-
servable effect was either not sustained for long periods
of time or not reported upon. In certain cases, even though
the intervention may have worked, the quality was assessed
as a quantifiable outcome and/or there were no specifically-
selected quality indicators to assess, for example, the long-
term effectiveness and sustainability of the intervention, as
the majority of the goals in the interventions were simply
to reduce the number of prescribed medicines [46] and
assess this at a specific point in the near future following
the implementation of the intervention.
Phase 2: Implementation and evaluation of the intervention
The intervention was designed on the basis of the TPB,
which has been identified as a promising model for be-
haviour change in general practice [47]. The content of
the intervention was culturally specific and developed
according to local legislation and requirements regarding
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cluded three main components: (a) the delivery of a one-
day educational course (b) poster demonstration with key
messages on medicine prescribing over a 4-week period,
and, (c) regular visits by a trained health care professional
(acting as informant) to the workplace of the participants,
coupled with reminder messages and email messages over
the 4-week period of the intervention.
All GPs allocated to the intervention group in each
participating country were invited to attend an intensive
one-day educational course. Issues on how GPs should
educate their patients regarding the risks of irrational
use of OTC medicines were addressed through the train-
ing, together with promoting collaboration with pharma-
cists. The course employed various educational techniques
such as lectures, role-play and small group discussions.
Key lectures informed the participants about the available
literature on the principles of rational prescribing, adverse
reactions to drugs, drug interactions and health risks re-
lated to their misuse [24,48].
The educational course, also, included interactive train-
ing methods in addition to conventional lectures, while a
number of clinical scenarios were used to stimulate debate
on the treatment options in the small group discussions
[27,49]. Role-play procedures were also employed to en-
courage participants to become actively involved in the
discussion.
Supporting materials, such as posters placed at the
workplace of participants and alert messages (text or
email messages) for physicians, were used during the
intervention as “reminder tools” aimed at raising partici-
pant awareness [50]. The reminder tools contained short
and concise messages related to the prevention of ir-
rational use of medicines, the careful provision of OTC
medicines as well as the promotion of patient safety.
Furthermore, regular visits by health care professionals
were made to the workplace of the participants over a 4-
week period; these health care professionals had previ-
ously received a 3-hour training session by the research
team in each participating country. These visits involved
personal communication with the study participants and
delivery of written material, which served as reminders
of the main aim and objectives of the intervention in the
context of everyday practice.
Instruments, measurements and outcomes of the pilot
educational intervention study
1) Training assessment questionnaire
The Training Assessment Questionnaire aimed to evaluate
various aspects of the one-day training seminar. Seven-
point Likert scale items related to the quality of the sem-
inar and its speakers (1 = high/7 = low), its potential impact
on GPs’ behaviour regarding OTC medicines and their
practice regarding the issue of prescribing (1 = stronglydisagree/7 = strongly agree) as well as its applicability on
their future work (1 = not important/7 = important) were
used. Questions in the Training Assessment Questionnaire
were not analysed for France, since a different version of
the questionnaire was employed.
2) Complementary questionnaire on OTC medicines
A complementary questionnaire was used to elicit informa-
tion focusing on OTC medicines. This 11-item question-
naire explored the attitudes and behaviour of GPs towards
OTC medicines, and consultation about OTC medicines to
their patients, and included closed and open-ended ques-
tions, as well as a series of scenarios based on real patient
situations. These scenarios were developed on the basis of
the key findings of this European project (Work packages 3
and 4) in the participating countries. The questionnaire was
distributed to participating GPs serving both in the inter-
vention and the control groups. It also contained post-
intervention questions responded to by the participants in
the intervention groups on a 7-point Likert scale (1 = very
bad/7 = very good) in an attempt to collect quantitative and
qualitative data regarding the intervention. The groups in
France did not complete the post-intervention question-
naires due to local and organisational barriers.
3) TPB questionnaire
This questionnaire was constructed under the guidance
of a previously implemented FP5 project, the Research-
Based Education and Quality Improvement (ReBEQI)
project which aimed to create a framework for selecting
and ensuring the implementation of interventions towards
the improvement of quality of healthcare. The question-
naire was distributed to all participating GPs in both inter-
vention and control groups [48]. It was initially developed
and tested in the Greek language and was then translated
into six European languages [16]. All the questionnaires
utilised in this pilot study have been culturally tested prior
to their implementation in the participating settings. A
short version of the original questionnaire was adminis-
tered before and after the intervention (pre- and post-
intervention phases) with the aim to assess the variations
in attitudes, social norms, perceived behaviour control
and intentions regarding the provision and consumption
of medicines. The primary focus was placed on three dif-
ferent dimensions of intention towards provision of medi-
cines, namely “Generalized Intention towards medicine
provision” (GI), “Intention Performance Statement 1”
(IPS1), which expressed GP expectation to provide medi-
cines, and “Intention Performance Statement 2” (IPS2),
which expressed GP expectation to issue a prescription
without having well-documented evidence about their pa-
tient. All items were measured on a seven-point Likert
scale except for the Intention performance statements
(IPS1 & IPS2), which were measured on a 10-point scale.
Lionis et al. BMC Family Practice 2014, 15:34 Page 6 of 15
http://www.biomedcentral.com/1471-2296/15/344) Patient medication form
Provision of medicines was measured through the review
and analysis of the medical records of five patients per
GP in both groups (intervention and control) before and
after the intervention. The first five consecutive patients
aged 60 years and over, visiting the GPs’ practice to seek
a prescription, were selected to participate in the study.
The number of prescribed medicines was recorded before
and after the intervention in order to identify changes in
the provision of medicines [18,27]. The measure of inter-
est was the difference between the number of medicines
prescribed in the last visit before the intervention and the
first visit after the intervention.
Outcomes of the pilot educational and intervention study
The primary outcome of this study was to investigate if
there was a reduction in GPs’ intention to prescribe medi-
cines following the educational intervention. Intention to
provide medicines was measured at pre- and post-
intervention phases in both control and intervention
groups by utilizing three TPB scales, namely GI, IPS1
and IPS2. A secondary outcome was to investigate
whether there was an overall reduction in the number
of medicines prescribed by GPs to a selected group of
their patients following the intervention, and in com-
parison to the baseline. Secondary outcomes included
the acceptance and practicality of the educational inter-
vention as evaluated by the participating GPs.
Acceptance
The acceptance of this intervention was assessed by exam-
ining responses to questions regarding the organization
and the content of the overall training. Additionally, the
one-day seminar in its entirety, the quality of the speaker
presentations and the overall quality of the intervention
according to the expectations GPs had prior to attending
the seminar were also evaluated. Acceptance-related ques-
tions were included in the Training Assessment Question-
naire as well as in the Complementary Questionnaire on
OTC medicines. Overall, participating GPs were willing
to be randomized into the two study groups; no prob-
lems were reported in the patient recruiting process.
Internal consistency of Acceptance-related questions
found in both questionnaires was satisfactory with
Cronbach’s alpha index being a = 0.821 (in Complemen-
tary questionnaire) and a = 0.656 in Practicality-related
items found in the Complementary Questionnaire and
in 1-day training questionnaire respectively.
Practicality
The practicality of the intervention was evaluated via
analyses of questions related with GPs’ work and prac-
tice. The aim was to assess whether GPs believed that
this intervention programme could affect their practicesin the matter of prescribing. Thus, GPs were invited to
assess whether this intervention changed their view of
OTC medicines, whether it was helpful for their future
work, if the themes of the seminar changed their views
in the issue of prescribing and their behaviour towards the
use of non-prescribed drugs. These items were selected
from both the Complementary Questionnaire on OTC
medicines and the Training Assessment Questionnaire
The internal consistency of practicality-related questions
relevant for the 1-day training questionnaire was satisfac-
tory (Cronbach’s alpha index a = 0.690).
Data collection
Interviewers were employed in each participating coun-
try in order to collect and extract the data from all ques-
tionnaires. Electronic database files were filled in by
each participating country by the participating GPs and
subsequently sent for merging, management and ana-
lyses at the Biostatistics Laboratory, Faculty of Medicine
of University of Crete, Greece, where a common data-
base has been created.
Data analysis
The acceptance and practicality of the intervention were
evaluated using descriptive analysis of the items men-
tioned in the Study evaluation section. The Chi-square
test of independence and the non-parametric Kruskal-
Wallis test were applied in order to investigate differences
in the sociodemographic characteristics of respondents.
The Mann–Whitney non-parametric test was applied to
compare differences between intervention and control
group. The level of statistical significance was chosen to




Eighty-four general practitioners participated in the study
(Cyprus n = 10, France n = 9, Greece n = 17, Malta n = 25
and Turkey n = 23). The control group consisted of 48
GPs (Cyprus n = 5, France n = 5, Greece n = 12, Malta n =
14 and Turkey n = 12) and the intervention group of 36
GPs (Cyprus n = 5, France n = 4, Greece n = 5, Malta n =
11 and Turkey n = 11). The proportion of complete data
was fairly high in the East Mediterranean countries (100%
in Malta, Turkey and Cyprus, and 90.5% in Greece) yet
lower in France where 45% of respondents completed all
the study pre-intervention questionnaires including the
follow-ups without missing data.
The sociodemographic characteristics of the GPs (Table 1)
varied significantly amongst participants. Cypriot, Turkish
and Greek physicians were on average younger (median
40 years in Cyprus and Turkey, and 42 years in Greece)
than their Maltese (47 years) and French colleagues
Table 1 Sociodemographic characteristics of respondents
Cuprus France Greece Malta Turkey P-value
Total cases 10 9 17 25 23
Gender 0.7031
Male n (%) 8(80.0) 6(66.7) 9(52.9) 15(60.0) 15(62.5)
Female n (%) 2(20.2) 3(33.3) 8(47.1) 10(40.0) 8(34.8)
Mean age 40 52 42 47 40 0.0022
Type of service area
Rural/Semi-urban/Other 4(40) 0(0) 17(100) 14(56.0) 17(73.9) <0.00013
Urban 6(60.0) 9(100) 0(0) 11(44.0) 6(26.1)
Years of experience
0-10 Years 7(70.0) 0(0) 11(64.7) 8(32.0) 3(13.0) <0.00014
>10Years 3(30.0) 9 (100) 6(35.3) 17(68.0) 20(87.0)
Kind of organization
Private/Combination/Don’t know/Other 4(40.0) 8(88.9) 0(0.0) 19(76.0) 0(0) <0.00015
Public 6(60) 1(11.1) 17(100) 6(24.0) 23(100)
Organizational type
Health center/Hospital 6(60.0) 0(0) 17(100) 8(32.0) 23(100) <0.00016
Independent/Chain/Group/Other 4(40.0) 9(100) 0(0) 17(68.0) 0(0)
1The chi-squared test of independence was applied X2 = 6.499 (d.f. = 4).
2The non parametric Kruskal-Wallis Test was applied X2 = 18.132 (d.f. = 4).
3The chi-squared test of independence was applied X2 = 35.131 (d.f. = 4).
4The chi-squared test of independence was applied X2 = 26.502 (d.f. = 4).
5The chi-squared test of independence was applied X2 = 53.413 (d.f. = 4).
6The chi-squared test of independence was applied X2 = 53.519 (d.f. = 4).
Lionis et al. BMC Family Practice 2014, 15:34 Page 7 of 15
http://www.biomedcentral.com/1471-2296/15/34(52 years). Age variations matched the variation in the clin-
ical experience of GPs; all French physicians had > 10 years
of experience, whereas 70% of the Cypriot physicians had <
10 years of practice (p < 0.0001). The primary care setting
also varied significantly among the participating countries,
with Greek and Turkish physicians serving the public sec-
tor in Health Centres/Hospitals and the majority of French
and Maltese physicians serving the private sector.
Intentions & number of medicines
Median scores and median differences in TPB measures
concerning intentions are presented in Table 2. A pattern
of positive changes was observed in the intervention
groups in East Mediterranean countries, with the median
intention scores being reduced after the intervention,
whilst, smaller or no changes were observed in the respect-
ive control groups. Statistically significant differences were
observed in Cyprus (GI; p-value = 0.018, IPS2; p-value =
0.017) and in Malta (IPS1; p-Value = 0.021). Besides TPB
measures, prescription patterns were evaluated using the
Patient Medication Form questionnaire. Information from
this questionnaire is also presented in Table 2. There was
no observable change in the number of prescribed medi-
cines recorded (pre- and post-intervention) in Cyprus and
Greece, while in France there was a small increase in the
number of prescribed medication. In Malta and in Turkeya small decrease in the number of prescribed medicines
was observed in both groups without it being statistically
significant.
Acceptance
The organization and content of the training received posi-
tive evaluation by all participating countries with median
scores being equal or greater than 5 on a 7-point Likert
scale (Figure 1). The material of the intervention was posi-
tively assessed in Cyprus, France and Turkey (median
scores ≥ 6 on a 7-point Likert scale), while it was neutrally
assessed in Greece and Malta. The same pattern was re-
ported in the relevant items found in the Training Assess-
ment Questionnaire. The seminar, in its entirety, received
high assessment scores (≥ 6 on a 7-point Likert scale), with
a very good overall quality of speakers (≥ 5 on a 7-point
Likert scale), and it was considered to be of fairly good
quality according to the expectations physicians had prior
to participation (Figure 2). Together, these results indicate
a high degree of acceptance by all participating countries
especially those in the East Mediterranean region where
the proportion of completed questionnaires was higher.
Practicality
GPs from the East Mediterranean countries (Cyprus,
Greece, Malta and Turkey) noted that the intervention
Table 2 GPs TPB intentions per country and group











GI 4.0 0.0 6.5 1.0 0.018
(3.0, 5.0) (−1.0, 0.0) (4.0, 7.0) (0.0, 2.0)
IPS1 8.0 0.0 8.00 1.00 0.419
(6.0, 9.0) (−1.0, 1.0) (5.0, 10.0) (0.00, 1.00)
IPS2 0.0 0.00 2.0 2.0 0.017
(0.0, 2.0) (−1.0, 0.0) (2.0, 7.0) (0.0, 3.0)
No. of prescribed medicines 4 (2, 7) 0 (0, 0) 4 (2, 4) 0 (0, 0) 1.000
France
GI 4.5 0.0 4.5 0.5 0.707
(3.0, 6.0) (−3.0, 1.5) (3.0, 6.0) (−1.0, 4.0)
IPS1 7.0 1.00 6.0 −0.5 0.209
(6.0, 9.0) (−1.0, 2.0) (6.0, 7.0) (−3.0, 1.0)
IPS2 5.0 1.0 3.5 0.5 0.156
(3.0, 7.0) (0.0, 2.0) (2.0, 5.0) (−3.0, 1.0)
No. of prescribed medicines 4 (2, 9) −1 (−1, 2) 4 (2, 9) −1 (−4, 2) 0.707
Greece
GI 3.5 0.0 4.0 1.0 0.351
(1.0, 6.0) (−3.0, 3.5) (2.5, 5.0) (−1.5, 3.5)
IPS1 5.5 0.0 6.0 1.0 0.340
(2.0, 9.0) (−3.0, 4.0) (3.0, 8.0) (0.0, 2.0)
IPS2 3.0 0.0 4.0 1.0 0.227
(0.0, 7.0) (−2.0, 2.0) (1.0, 8.0) (−1.0, 4.0)
No. of prescribed medicines 4 0 3 0 0.477
(1, 6) (−1, 1) (1, 5) (0, 0)
Malta
GI 4.0 0.5 4.3 1.0 0.108
(2.0, 7.0) (−1.5, 1.5) (2.0, 7.0) (−1.00, 3.0)
IPS1 6.0 0.5 7.00 1.0 0.021
(3.0, 9.0) (−1.0, 3.0) (4.0, 9.0) (1.0, 4.0)
IPS2 2.0 0.0 3.0 1.0 0.154
(0.0, 9.0) (−1.0, 2.0) (0.0, 10.0) (−1.0, 6.0)
No. of prescribed medicines 3 1 3 1 0.152
(2, 4) (−1, 1) (2, 5) (0, 3)
Turkey
GI 4.5 0.8 4.0 0.0 0.419
(2.50, 6.0) (−3.0, 2.5) (1.0, 6.0) (−4.5, 2.0)
IPS1 7.5 0.0 8.0 1.0 0.549
(6.0, 10.0) (−2.0 7.0) (0.0, 9.0) (−6.0, 4.0)
IPS2 4.5 0.5 3.0 1.0 0.804
(2.0, 9.0) (−8.0, 8.0) (0.0, 8.0) (−5.0, 7.0)
No. of prescribed medicines 4 1 4 1 0.612
(2, 6) (−1, 4) (3, 7) (0, 2)
*Differences were computed for each measure by subtracting the scores after intervention from the baseline scores.
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Figure 1 Acceptance related questions (complementary questionnaire on OTC medicines).
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http://www.biomedcentral.com/1471-2296/15/34changed their view on OTC medicines (median scores ≥
5 on a 7-point Likert scale) while in France that question
was neutrally assessed. Based on responses to selected
items of the Training Assessment Questionnaire, physi-
cians in all participating countries perceived the seminar
as useful for their future practice and considered that its
themes could potentially influence their prescribing
practices and their views on OTC medicines’ consump-
tion. Higher scores in the above statements were ob-
served in Cyprus, Turkey and Greece compared with
Malta (Figure 3).
Other measures
Results from the Complementary Questionnaire in OTC
medicines also indicated a favourable change towards a
more rational prescribing in intervention groups. GPs
were asked how they would respond in a situation where
a visiting patient or third person (friend/relative of the pa-
tient) asked them to prescribe medicines already bought
from the pharmacy. The rate of non-compliance with such
behaviour was found to be higher after the intervention. A
similar pattern was observed when GPs were asked how
they would respond in a situation of a regular-visiting pa-
tient asking for a medicines’ prescription for medicines
suggested by another physician. Post-intervention replies
included rational medicine-provision patterns such as
contact with the other physician prior to prescription at a
higher extent compared to baseline responses (Figures 4,
5 and 6). To explore physician behaviour regarding appro-
priate use of OTC medicines, GPs were asked whether it
is important to include information on OTC medicine use
in their consultation and, if so, how often. After the
intervention, the frequency of those who responded thatthey should include information on OTC use in each
consultation was increased compared to baseline in the
intervention group, while it was reduced in control group.
Furthermore, the frequency of those who responded that
they should include information on OTC use only in cer-
tain cases was reduced in the intervention group contrary
to the control group where it remained unchanged. Re-
sults are depicted in Figure 7.
Discussion
Main findings
The main finding of this feasibility study suggests that an
intervention designed on the basis of TPB aimed at modi-
fying GPs’ behaviour towards prescribing or recommend-
ing OTC medicines was considered to be well-accepted
and practical according to the evaluation by participating
physicians. A higher degree of acceptance and practicality
was observed in settings from the East Mediterranean
region where the problem of irrational use of OTC
medicines seems to be more significant. Although the
feasibility study indicated a limited efficacy regarding
physicians’ prescribing patterns as measured by the
TPB, the data of this study show a favourable intention
towards irrational prescription. Additionally, the study
adds evidence confirming that translating theory into
practice is feasible.
To our knowledge, such an intervention has not been
previously implemented in this geographic area, where ra-
tional prescribing and use of OTC medicines and pharma-
ceutical costs are key issues for the current health care
and health policy agenda [51-53].
Evidence from this study indicated that the interven-
tion that was carried out could play a significant role
Figure 2 Acceptance related questions (training assessment questionnaire).
Lionis et al. BMC Family Practice 2014, 15:34 Page 10 of 15
http://www.biomedcentral.com/1471-2296/15/34towards the improvement of the previously described
current conditions. GPs’ intentions, as approached by
the TPB, were reduced post-intervention towards less
favourable attitudes regarding medicine provision. This
pattern was backed up by a reduction in the number of
medicines that GPs provided to their patients after the
intervention, as observed in Malta and in Turkey. In
parallel with the above, a change towards a moreFigure 3 Practicality related questions (complementary questionnairerational behaviour in situations regarding prescription to
third persons or medicines already bought from pharma-
cies was observed. It is evident, that the combination of
the above findings suggests a well-targeted approach
concerning GPs behaviour. On the other hand, this
intervention was not directly targeted towards the be-
haviour modification of pharmacists or patients. It
should be stressed that the issue of polypharmacy is noton OTC medicines & training assessment questionnaire).
Figure 4 Complementary questionnaire on OTC medicines 1.
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http://www.biomedcentral.com/1471-2296/15/34solely dependent on the behaviour of GPs. A schematic
representation of these three groups would be a triangle,
with GPs on one side, pharmacists and patients on the
other two sides. Behaviours and interactions between all
sides ought to be approached by a larger scale interven-
tion with multiple targets in order to assess whether
such designs could be effective enough to promote a
better management of the recorded situation.Figure 5 Complementary questionnaire on OTC medicines 2.Strengths and limitations
This study attempted to identify the potential impact of
an educational intervention on GPs’ prescribing practices.
Such interventions have been widely recommended in the
international literature [30]. Among the strengths of this
intervention is the fact that it was based on a clearly speci-
fied theoretical framework, the TPB model, and there is
some evidence demonstrating that the concepts of this
Figure 6 Complementary questionnaire on OTC medicines 3.
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text of prescribing [53]. Additionally, this study was im-
plemented in Mediterranean countries of the Southern
European region were such interventions are lacking.
The intervention was focused solely on GPs, thus the
lack of involvement of pharmacists and/or patients/cli-
ents in the intervention represents a limitation. We
involved purposively only GPs without inviting patients
and pharmacists as the involvement could artificially
enhance the effectiveness of the pilot study. AnotherFigure 7 Complementary questionnaire on OTC medicines 4.potential limitation of this study is that its feasibility was
tested in selected districts of each participating country
where a convenience sampling led to different GP demo-
graphics; all of these limitations introduce a degree of bias
and may limit the generalisability of the results of the study,
and also limit the external validity of the study. A conveni-
ence sampling was performed for GP practice selection in
participating countries and, thus, our findings may be less
amenable to drawing conclusions for the GPs in the various
countries. Another limitation of the study is the lack of
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found to be well-accepted by participating GPs, one cannot
safely infer regarding its acceptance on a larger scale. In
addition, it should be noted that the French GP uptake in
this study was extremely low. This introduces a high risk in
making safe inferences drawn from this particular group or
comparisons to other settings, thus, the results of the pilot
study at this point should be interpreted with some caution.
In addition, the differences on sociodemographic data
among the participating GPs may have an impact on the
interpretation of the data on effectiveness. Finally, the tools
that were used for the evaluation of the intervention were
theoretically sound, but not tested in terms of their reliabil-
ity and validity in the population of interest.
In addition to the above issues, there are concerns
regarding existing differences with regards to cultural and
organisational heterogeneity, and the dispensing policy
within the various primary care setting may have an impact
on the interpretation of the study results. Although the
background data to the project support that Greece, Malta,
Cyprus and Turkey are very similar in the provision of pri-
mary care services, it is noted that variations from country
to country in terms of the GPs practices, culture and
doctor-patient relationship among the participating settings
exist and they have been recorded in general terms. We did
not adjust the existing differences in the pilot intervention,
however; this was out of the scope of the current
pilot feasibility study which aimed to assess effectiveness,
practicality and acceptance in the local settings. We wish to
underline that this issue should be taken into consideration
in future RCT studies.
This feasibility study attempted to address the pragmatic
conditions existing in each setting. Although certain
similarities exist among the different country settings,
there are clear differences in the organization of primary
care services, in the prevailing health culture of the patients
as well as in the demographic characteristics. Certainly, as
previously mentioned, this restricts the generalisability of
the study findings, and we would draw attention to the fact
that these should be interpreted carefully within each
unique political and cultural setting.
Impact of the study
This study is particularly timely, as certain European
countries are currently facing a financial crisis, while at
the same time physicians and pharmacists seem to pro-
vide medicines to a large number of patients often as a
result of social pressure. This feasibility study, despite its
limitations, could provide valuable insights for a large-
scale study. Qualitative studies and the analysis of em-
pirical data may prove valuable in highlighting areas of
research, which should be taken into consideration
when designing such trials. This intervention study also
highlighted the GPs’ high expectation for guidance andtraining and this could be a key issue in health care re-
forms currently discussed and implemented in Southern
European countries. Most importantly, the current inter-
vention was tested in various settings and a proposed inter-
vention frame has been evaluated as feasible, well-accepted
and practical in the busy health care environment. The
study further provides an operationalized structure to de-
fine and evaluate interventions targeting similar behaviours
in health professions and other disciplines. It introduces
common evaluation standards and tools translated in mul-
tiple European languages, appropriate for measuring the
effectiveness of current interventions and their applicability
in other settings. Researchers now have access to an educa-
tional intervention tool with relevant methodologies and in-
struments for a future large-scale implementation, to alter
the existing situation at the regional and national levels,
allowing for substantial curbing of pharmaceutical expendi-
tures. Furthermore, the current study provides evidence to
policy makers on future policy actions targeting physician
skills and prescribing behaviours in primary health care. It
can additionally provide guidance on how to manage phys-
ician behavioural change and how to prevent irrational pre-
scribing of medicines at primary care settings, through
borrowing theoretical constructs from behavioural sciences.
These constructs could be used in undergraduate, post-
graduate and continuous medical education, to improve
medical practice. This study is further expected to enable
multi-country, multi-stakeholder consultations regarding
long-term planning for the provision and consumption of
medicines.
Conclusions
The content, constructs and methods of the designed pilot
intervention study highlighted aspects of feasibility and
elements of acceptance although certain methodological
issues, including the selection of the different groups within
the different European cultural and organisational settings,
may have an impact on the interpretation of the results and
on future transferability. This study also advocates the
implementation of well-designed randomized studies in this
field and highlights certain essential components for
successful implementation of future interventions and
research studies. The results of the current study may
provide sufficient information to GPs and health policy
makers to promote large-scale research, which is an issue
of importance in certain European countries and especially
those that have been affected by the financial crisis.
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